Validation of the Japanese version of the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)

Growth Hormone and IGF Research

Volumn 16, Issue 5-6, 2006, Pages 340-347

  Suzukamo, Yoshimi ^a,b   Noguchi, Hiroyuki ^c   Takahashi, Natsuko ^d   Shimatsu, Akira ^e   Chihara, Kazuo ^f   Green, Joseph ^b,g   Fukuhara, Shunichi ^b,h  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Institute for Health Outcomes and Process Evaluation Research   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d Japan Council for Quality Health Care   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^f KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h KYOTO UNIVERSITY   (Japan)

Author keywords

Growth hormone deficiency in adults; Measurement; QoL AGHDA; Quality of life; Validation

Indexed keywords

GROWTH HORMONE;

ADULT; AGED; ARTICLE; CLINICAL OBSERVATION; CLINICAL PROTOCOL; CONCURRENT VALIDITY; CONTENT VALIDITY; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INTERNAL CONSISTENCY; JAPAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; SCORING SYSTEM; SHORT FORM 36;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMAN GROWTH HORMONE; HUMANS; JAPAN; LANGUAGE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; QUESTIONNAIRES; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 33751292928     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.09.002     Document Type: Article

References (30)

1. Rudman D., Kutner M., and Rogers C. Impaired growth hormone secretion in the adult population. Relation to age and adiposity. J. Clin. Invest. 67 (1981) 1361-1369
2. Salomon S., Cuneo R., Hesp R., and Soènksen P. Growth hormone deficiency in adults. Acta. Paediatr. Scand. 356 (1989) 69
3. Woodhouse L.J., Mukherjee A., Shalet S.M., and Ezzat S. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr. Rev. 27 (2006) 287-317
4. Blizzard R., Joyce S., Mitchell T., et al. Psychosocial impact of long-term growth hormone therapy. In: Raita S., and Tolman R. (Eds). Human Growth Hormone (1986), Plenum, New York 93
5. Hunt S.M., McKenna S.P., McEwen J., Williams J., and Papp E. The Nottingham health profile: subjective health status and medical consultations. Soc. Sci. Med. 15 (1981) 221-229
6. Dupuy H. The psychological general well-being (PGWB) index. In: Wenger N.K. (Ed). Association of quality of life in clinical trials of cardiovascular therapies (1984), Le Jacq Publications, New York 170-183
7. Ware J.E., and Sherburne C.D. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med. Care. 30 (1992) 473-489
8. Fukuhara S., Bito S., Green J., Hsiao A., and Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J. Clin. Epidemiol. 51 (1998) 1037-1044
9. Cuneo R.C., Judd S., Wallace J.D., et al. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J. Clin. Endocrinol. Metab. 83 (1998) 107-116
10. Wallymahmed M.E., Baker G.A., Humphries G., Dewey M., and MacFarlane I.A. The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency. Clin. Endocrinol. (Oxf) 44 (1996) 403-411
11. McKenna S.P., Doward L.C., Alonso J., et al. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual. Life Res. 8 (1999) 373-383
12. Herschbach P., Heinrich G., Strasburger C.J., et al. Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency. Eur. J. Endocrinol. 145 (2001) 255-265
13. Doward L.C., McKenna S.P., and Meads D.M. Effectiveness of needs-based quality of life instruments. Value Health. 7 (2004) S35-S38
14. Bengtsson B.A., Abs R., Bennmarker H., et al. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS study group and the KIMS international board. J. Clin. Endocrinol. Metab. 84 (1999) 3929-3935
15. Svensson J., Mattsson A., Rosen T., et al. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption. Growth Horm. IGF Res. 14 (2004) 207-215
16. Feldt-Rasmussen U., Wilton P., Jonsson P., KIMS Study Group, and KIMS International Board. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults. Growth Horm. IGF Res. 14 (2004) S51-S58
17. Guillemin F., Bombardier C., and Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J. Clin. Epidemiol. 46 (1993) 1417-1432
18. Lohr K.N., Aaronson N.K., Alonso J., et al. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin. Ther. 18 (1996) 979-992
19. Wiren L., Whalley D., McKenna S., and Wilhelmsen L. Application of a disease-specific, quality of life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by Rasch analysis. Clin. Endocrinol. 52 (2000) 143-152
20. Cronbach L.J. Coefficient alpha and the internal structure of tests. Psychometrika 16 (1951) 297-334
21. Fayers P.M., and Machin D. Cronbach's alpha and internal consistency. Quality of Life: Assessment, Analysis and Interpretation (2000), John Wiley & Sons 85-87
22. Kramer M.S., and Feinstein A.R. Clinical biostatistics LII: the biostatistics of concordance. Clin. Pharmacol. Ther. 26 (1981) 111-123
23. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 8476 (1986) 307-310
24. Fayers P.M., and Machin D. Reliability. Quality of Life: Assessment, Analysis and Interpretation (2000), John Wiley & Sons 57-65
25. Tabachinik B.G., and Fidell L.S. Using Multivariate Statistics. second ed. (1989), HarperCollins, New York
26. Kline P. An Easy Guide to Factor Analysis (1994), Routledge, London
27. Chihara K., Kato Y., Kohno H., Takano K., Tanaka T., Teramoto A., and Shimatsu A. Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study. Growth Horm. IGF Res. 16 2 (2006) 132-142
28. Fukuhara S., and Suzukamo Y. Manual of SF-36v2 Japanese version (2004), Institute for Health Outcomes and Process Evaluation Research, Kyoto
29. WHO. Obesity: Preventing and Managing the Global Epidemic (1997), WHO/NUT/NCD, Geneva
30. Barkan A.L. The "Quality of life-assessment of growth hormone deficiency in adults" questionnaire: can it be used to assess quality of life in hypopituitarism?. J. Clin. Endocrinol. Metab. 86 (2001) 1905-1907